Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle.

Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle.
复制标题

DOI:
10.1038/ncomms9526
复制
发表时间:
2015-10-08
影响因子:
16.6
通讯作者:
Ward CW
Ward CW
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Kerr JP;Robison P;Shi G;Bogush AI;Kempema AM;Hexum JK;Becerra N;Harki DA;Martin SS;Raiteri R;Prosser BL;Ward CW

文献摘要

被引文献

相似文献

在横纹肌中,X-ROS是微管网络传递的机械应力激发活性氧的机械传导途径。X-ROS调节健康肌肉中的Ca 2+信号传导,但在杜氏肌营养不良症(DMD)等疾病中,微管改变驱动X-ROS升高,破坏Ca 2+稳态并损害功能。在这里,我们表明,脱酪氨酸,α-微管蛋白的翻译后修饰,影响X-ROS信号,收缩速度和细胞骨架力学。在DMD的mdx小鼠模型中,体外脱酪氨酸的药理学减少消除了异常的X-ROS和Ca 2+信号传导,并且在体内它可以防止DMD的特征,包括工作负荷诱导的心律失常和骨骼肌收缩诱导的损伤。我们的结论是,脱酪氨酸微管增加横纹肌的细胞骨架刚度和机械转导,并针对这种翻译后修饰可能有广泛的治疗潜力,在肌营养不良症。 微管是肌肉细胞中机械能的转换器。在这里,作者表明,机械转导是由小鼠心脏和骨骼肌中微管的翻译后脱酪氨酸调节的,并且减少脱酪氨酸可以改善杜氏肌营养不良症模型的症状。
In striated muscle, X-ROS is the mechanotransduction pathway by which mechanical stress transduced by the microtubule network elicits reactive oxygen species. X-ROS tunes Ca2+ signalling in healthy muscle, but in diseases such as Duchenne muscular dystrophy (DMD), microtubule alterations drive elevated X-ROS, disrupting Ca2+ homeostasis and impairing function. Here we show that detyrosination, a post-translational modification of α-tubulin, influences X-ROS signalling, contraction speed and cytoskeletal mechanics. In the mdx mouse model of DMD, the pharmacological reduction of detyrosination in vitro ablates aberrant X-ROS and Ca2+ signalling, and in vivo it protects against hallmarks of DMD, including workload-induced arrhythmias and contraction-induced injury in skeletal muscle. We conclude that detyrosinated microtubules increase cytoskeletal stiffness and mechanotransduction in striated muscle and that targeting this post-translational modification may have broad therapeutic potential in muscular dystrophies. Microtubules are transducers of mechanical energy in muscle cells. Here, the authors show that mechanotransduction is regulated by post-translational detyrosination of microtubules in mouse heart and skeletal muscle, and that reducing detyrosination ameliorates symptoms in a model of Duchenne muscular dystrophy.